StudyFinder

MT2022-49: Early identification of cognitive side-effects of immunotherapy

Status: Recruiting

This study is testing different ways to look for neurologic side effects in patients who get CAR-T therapy for their cancer.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• planning to have inpatient CAR-T therapy for primary cancer
• fluent in English (written or spoken)
Exclusion Criteria:

• presence of speech or hearing problem
• diagnosis of cognitive impairment
Interventions:

Other: Non-Interventional Study

Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC), CAR-T, Chimeric Antigen Receptor T-Cell Therapy

Study Contact: Veronika Bachanova - bach0173@umn.edu
Principal Investigator: Veronika Bachanova, MD
IRB Number: STUDY00019811
See this study on ClinicalTrials.gov

Back